Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Warsaw - City that cares (WAW-CTC)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EU prize
Destination: European Capital of Innovation Awards
Action type: Recognition Prize
Countries involved: Poland
Call: The European Capital of Innovation Awards iCapital 2023 (HORIZON-EIC-2023-ICAPITAL-PRIZE-02, 2023)
Total project cost (EUR): 0.0
EU funding (EUR): 0.0
Participants: 1
Project status: SIGNED

Warsaw is a hub of innovation, led by its active and creative citizens. This year, the city adopted the slogan, "Warsaw - city that cares," emphasizing its commitment to creating a safe, free, and homely environment conducive to innovation. Despite geopolitical crises and economic challenges, Warsaw demonstrated resilience, ranking 6th in The Financial Times' "FDI Intelligence - European Cities and Regions of the Future". It also ranked 2nd for business friendliness and received high economic ratings in the Mazovian region. Quality of life is a significant factor in Warsaw. In the "Cities of Choice" ranking by Boston Consulting Group, Warsaw was placed 4th globally, commended for transportation, income equality, education, and overall city development. The city also prioritizes social capital, with robust nursery and kindergarten networks, support programs for women, and partnerships with over 10,000 NGOs. Civic activity is high in Warsaw, with over 90,000 residents participating in participatory budget voting. The city also shows its care for seniors, people with special needs, and those with disabilities by ensuring accessibility in various domains. For these efforts, Warsaw received the "Access City Award" from the European Commission in 2020. In 2022, Warsaw was named "European Best Destination," reflecting its cultural richness and positive changes. The city continues to develop, building green, sustainable, and cultural areas without neglecting its historical significance. As a part of these changes, the city is investing in open-source solutions, data sharing, digital services, and IoT infrastructure, all contributing to the city as a platform idea. Warsaw's innovative approach to change and development, along with its resilience and pursuit of balanced growth, makes it a truly innovative capital city.

Keywords: city that cares,active residents,friendly place,open metropolis,e mobility,connecting locally and globally,diversity,accessibility,city as a platform,crisis management,smart sme s
Agency in Law (LEGACY)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Institutions, Governance and Legal Systems
Panel description: Political science, international relations, law
Countries involved: Finland
Call: ERC STARTING GRANTS (ERC-2023-STG, 2023)
Start date: 2024-01-01
End date: 2028-12-31
Duration (months): 60.0
Total project cost (EUR): 1496595.0
EU funding (EUR): 1496595.0
Participants: 1
Project status: SIGNED

The distinction between agents and non-agents is central in law: only agents can decide about their affairs, enter contracts or be held responsible for their actions. Western law has since the 19th century relied on an understanding of agency that has developed in the liberal tradition of thought. According to this “Liberal Agency”, agents are highly rational human individuals. Persons with cognitive disabilities, artificial intelligences, and nonhuman animals are therefore not agents because of their lack of rationality or humanity. This view of agency is deeply embedded in Western legal systems. Liberal Agency has recently come under increasing criticism and challenges. Many now argue that persons with disabilities, artificial intelligences and/or nonhuman animals could in fact be treated as agents. However, these criticisms have been narrow in scope, and the debate is overall highly fragmented. LEGACY, situated within legal philosophy and history, will offer a comprehensive reappraisal of legal agency. It will investigate three main questions: First, how did Liberal Agency become the dominant understanding of agency in law? Second, what challenges confront Liberal Agency today? And finally, what kind of a theory can best explain the evolving notion of agency in law? The objectives of the project are to deliver: (1) a systematic understanding of the historical background and context of Liberal Agency, its spread in Western legal thought, and its challengers; (2) an in-depth analysis of contemporary agency accounts that incorporates and conceptualizes the historical insights with a systematic understanding of the contemporary debates; and (3) a theory of agency that provides an overall synthesis of the accounts and can explain, reconcile and/or solve the outlined contemporary challenges. The project will thus develop a historically informed, comprehensive and rigorous understanding of legal agency, based on a broad synthesis of legal and philosophical thought.

Keywords: agency,legal philosophy,jurisprudence,legal history
Ironclad Quantum Security of Code And Lattice-based cryptography (IQ-SCALe)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Computer Science and Informatics
Panel description: Informatics and information systems, computer science, scientific computing, intelligent systems
Countries involved: France
Call: ERC STARTING GRANTS (ERC-2025-STG, 2025)
Start date: 2026-01-01
End date: 2030-12-31
Duration (months): 60.0
Total project cost (EUR): 1420403.0
EU funding (EUR): 1420403.0
Participants: 1
Project status: SIGNED

Since Shor’s seminal algorithm, we know that quantum computers will break deployed public-key cryptography. Fortunately, there are quantum-safe solutions based on objects known as codes and lattices. These solutions were identified by an algorithm of Regev showing that if there is an attack, then a quantum compter will enable to solve problems believed to be intractable. Apart from this result, very few quantum algorithms were designed to assess or to break the security of code and lattice-based cryptography. IQ-SCALe is here to address this gap by opening a new and uncharted area for quantum algorithms. One of the motivations behind IQ-SCALe is a recent attack I designed against advanced cryptosystems. My attack based on Regev's approach demonstrates that it had not been sufficiently exploited. I also identified tools from Regev's approach to be at the core of a fundamental research area - sphere packing bounds - for which powerful generalizations are known. However, they involve more complicated objects (non-commutative groups) and the analogous quantum tools have not yet been designed. IQ-SCALe aims to design new quantum algorithms for this broader theory. Historically, Regev’s approach not only enabled us to assess the security of some cryptosystems by identifying an intractable problem, it was also leveraged to mount attacks as I have shown. The new quantum tools that I will design in IQ-SCALe will likewise lead to both the identification of useful cryptographic problems and the design of new algorithms for attacks and proofs of hardness. It will considerably increase our trust in code and lattice-based cryptography. Current quantum algorithms to assess the security of code and lattice schemes are adaptations to the quantum setting of classical approaches. This will not be the case for innovative algorithms of IQ-SCALe. But beyond algorithms, it will also create new connections between advanced mathematical areas and code and lattice-based cryptography.

Keywords: quantum computing,post quantum cryptography,lattice based cryptography,code based cryptography
Combating Multidrug-Resistant Gram-Negative Bacteria in Africa through Diagnostic and Antimicrobial Stewardship (ComBac-Africa)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Health
Theme: Public-private partnerships
Destination: Global Health EDCTP3
Action type: Research and Innovation actions
Partnership: EDCTP3 (JU-JTI)
Countries involved: Germany,Nigeria,Switzerland,Côte d'Ivoire,South Africa,Portugal,Guinea-Bissau
Call: Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials (HORIZON-JU-GH-EDCTP3-2024-01-two-stage, 2024)
Start date: 2025-05-01
End date: 2029-04-30
Duration (months): 48.0
Total project cost (EUR): 5869998.75
EU funding (EUR): 5869998.75
Participants: 12
Project status: SIGNED

Antimicrobial resistance is a major global health threat for humans, animals and the environment, with the highest mortality and morbidity rates in sub-Saharan Africa (SSA). The World Health Organization prioritised several carbapenem- and third-generation cephalosporin-resistant Gram-negative bacteria such as Enterobacterales as the most critical pathogens with only very limited treatment options. Bacteraemia, sepsis and other severe infections caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB) give rise to excess mortality. Yet, the causative pathogens are rarely identified in patients in SSA due to a lack of microbiological diagnostics. Carbapenems and the new antibiotics ceftazidime-avibactam, cefiderocol and aztreonam-avibactam are active against different MDR GNB and could significantly reduce morbidity and mortality, but they are not widely available in SSA. The ComBac-Africa consortium has the overall goal to improve the management of severe infections due to MDR GNB in Côte d’Ivoire, Guinea-Bissau and Nigeria through the establishment of a needs-adapted diagnostic and antimicrobial stewardship (AMS) programme that provides equitable access to these novel antibiotics for targeted treatment. This will be achieved through (1) provision of high-quality and accurate microbiological diagnostics for prompt and correct identification of causative agents in bacteraemia and other severe infections; (2) a comprehensive One Health assessment of the epidemiology of GNB in humans, animal and environmental specimens; (3) tailored AMS initiatives, including early outbreak detection and infection prevention measures, to optimise the use of novel antimicrobials; (4) development of clinical algorithms for targeted diagnosis and treatment of infections due to MDR GNB; and (5) establishment of sustainable and affordable access to these antibiotics in SSA. A clinical trial will assess and quantify the impact of this multi-pronged intervention on patient outcome.

Keywords: diagnostic stewardship,antimicrobial stewardship,multiresistant bacteria,carbapenemase
Quantum Control of Ultracold Molecules By Electric Fields (QUCUMBER)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Advanced grants
Action type: ERC actions
Panel: Physical and Analytical Chemical Sciences
Panel description: Analytical chemistry, chemical theory, physical chemistry/chemical physics
Countries involved: Netherlands
Call: ERC ADVANCED GRANTS (ERC-2023-ADG, 2023)
Start date: 2025-03-01
End date: 2030-02-28
Duration (months): 60.0
Total project cost (EUR): 3352573.0
EU funding (EUR): 3352573.0
Participants: 1
Project status: SIGNED

The study of molecular collisions at the lowest possible energy has emerged as an exciting research frontier. At low energies the wave-character of matter leads to exotic scattering phenomena that reveal the fundamental mechanisms of molecular collisions. Crossed beam methods are ideal to probe collisions with the highest detail, but the lowest energy currently achievable is not sufficient to fully harvest these possibilities. Building upon my recent breakthrough in state-to-state merged beam scattering at record-low energies, the aim of this project is to reduce the currently attainable collision energy by another 2-3 orders of magnitude by combining Stark deceleration, merged beams, laser cooling and velocity map imaging. Using two distinct systems that are characteristic for a large class of molecular interactions, I will measure hitherto unexplored quantum features in the state-to-state integral and differential cross sections. For atom-molecule systems, I will measure scattering resonances and image how the resonance region dominated by a few partial waves evolves into the pure quantum regime where only a single partial wave remains. For collisions between dipolar molecules, I will experimentally study a peculiar self-polarizing effect, probing fundamental features of the long-range dipole-dipole interaction that can be steered from attractive to repulsive. For both systems, I will manipulate the cross sections using external electric fields, and study how the partial waves transform during the collision. The proposed research program will directly visualize how molecular collisions transform from “hot” into “ultracold” at the full quantum mechanical level, providing excellent tests for quantum theories of molecular interactions. It will bridge the gap between the ultracold quantum physics and physical chemistry communities, and will lay the foundations for a new era in the rich history of elucidating molecular reaction dynamics using crossed molecular beams.

Keywords: crossed beam scattering,velocity map imaging,stark deceleration,cold collisions
Porous organic cage based covalent organic framework utilizing multicomponent reaction towards CO2 capture and CO2/CH4 separation (POCOF-CO2)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Germany
Call: MSCA Postdoctoral Fellowships 2024 (HORIZON-MSCA-2024-PF-01, 2024)
Start date: 2025-09-01
End date: 2027-08-31
Duration (months): 24.0
Total project cost (EUR): 202125.12
EU funding (EUR): 202125.12
Participants: 1
Project status: SIGNED

The escalating atmospheric levels of carbon dioxide (CO2) and methane (CH4) pose a critical threat to global climate stability, with CO2 contributing to prolonged thermal retention and CH4 exhibiting over 25 times the global warming potential of CO2 on a per-molecule basis over a century. To address these pressing challenges, the POCOF-CO2 project aims to revolutionize Covalent Organic Framework (COF) through the integration of Porous Organic Cages (POCs) as monomeric units. The project hypothesizes that POCs, with their precisely engineered cavities and functional groups, will significantly enhance the porosity, stability, and catalytic efficiency of COFs, thereby optimizing their gas capture capabilities. The project aims to optimize POC synthesis through a streamlined one-pot multicomponent reaction to enhance chemical stability and yield, integrate these POCs into COFs to improve structural diversity, stability, and scalability, and rigorously evaluate the COFs for CO2 capture and CO2/CH4 separation using advanced analytical techniques such as temperature-programmed desorption and sophisticated spectroscopy. The innovative one-pot MCR approach not only enhances POC stability but also simplifies production processes compared to conventional multi-step methodologies. This integration of MCR-derived POCs into COFs establishes a new benchmark in COF technology, offering unprecedented stability and performance. Advanced characterization techniques will deliver in-depth mechanistic insights into CO2 capture, addressing existing limitations and pushing the boundaries of COF research. The POCOF-CO2 project represents a significant leap forward in material science and environmental technology, contributing to global climate mitigation efforts and providing transformative applications in catalysis, energy storage and environmental remediation.

Keywords: gas sorption,adsorption isotherms,framework stability,post synthetic modification,pore size distribution
biogeniC gasEsous caRbon conversion into high added value chemicals and ingredients through a bio-based NETwork (CERNET)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Food, Bioeconomy Natural Resources, Agriculture and Environment
Theme: Public-private partnerships
Destination: Circular Bio-based Europe
Action type: Innovation actions
Partnership: CBE (JU-JTI)
Countries involved: Spain,Italy,Netherlands,Belgium,Greece,Denmark,Germany,Bulgaria,Slovenia,France
Call: Innovative conversion of biogenic gaseous carbon into bio-based chemicals, ingredients, materials (HORIZON-JU-CBE-2024, 2024)
Start date: 2025-06-01
End date: 2029-05-31
Duration (months): 48.0
Total project cost (EUR): 9901980.0
EU funding (EUR): 7498570.0
Participants: 21
Project status: SIGNED

Europe emits approximately 506.7 million tonnes of biogenic CO2 annually, much of which is released into the atmosphere. To harness this underutilized potential, it is essential to explore carbon capture and utilisation (CCU) pathways. CERNET aims to demonstrate the improved efficiency and sustainability of four Bio-Based Value Chains (BBVCs) that integrate four CCU systems using gaseous carbon sources (CO2 and CH₄) obtained from different industries, namely winery, waste management, and bioethanol production. These carbon sources, coupled with renewable energy will be used to produce six high-value chemicals and ingredients: L-alanine, protein hydrolysate, L-malic acid, sorbitol, PHA, and ectoine. The use of these products will be validated in the cleaning, cosmetics, packaging, and food industries. CERNET consortium comprises 21 partners from 10 EU countries, including underdeveloped bio-based sectors in Central and Eastern Europe. The team includes leading academia, technology developers, providers, and industrial partners from high biogenic carbon emitting sectors. Fourteen of the nineteen partners are Bio-based Industries Consortium (BIC) members, contributing significant self-funding and representing 26.2% of the project's in-kind contributions. CERNET aims to establish long-term strategies for adopting efficient CCU systems to convert biogenic gases, enhancing environmental performance over existing EU techniques. By producing chemicals and ingredients typically imported into the EU, the project aligns with the EU Industrial Strategy to bolster industry resilience and independence. Thanks to CERNET, up to 8.3 tonnes of gaseous carbon emissions will be abated in CERNET demonstrators. Replication and scalability will be driven by 16 Key Exploitable Results across technical, socioeconomic, policy, and academic domains. A Decision Support System tool based on the Emissions Trading System (ETS) market will facilitate expansion to other bio-based industries.

Keywords: biogenic carbon,ccu,value chain,fermentation,symbiosis,bio based products
Enabling Virtualized Wireless and Optical Coexistence for 5G and Beyond (EWOC)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Doctoral Networks
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Portugal,United Kingdom,Spain,Italy,Germany,Sweden,Finland,Poland
Call: MSCA Doctoral Networks 2021 (HORIZON-MSCA-2021-DN-01, 2021)
Start date: 2022-09-01
End date: 2027-09-30
Duration (months): 61.0
Total project cost (EUR): 2679202.29
EU funding (EUR): 2333469.6
Participants: 19
Project status: SIGNED

EWOC project aims at developing a novel converged optical wireless network solution relying on a flexible, virtualizable infrastructure, required for full resource optimisation beyond 5G (B5G) requirements. Fundamental innovation will be sought through merging of the enabling concepts of optical layer virtualization, high frequency mm-wave transmission, multiple antenna technology, cell densification, terra-over-fiber (ToF) based femtocell connectivity and cloud radio access network (C- RAN) architecture. EWOC will aim at high capacity, low latency communications (40-90 GHz frequency), providing the basis for a 50-fold improvement over the 5G baseline. This necessitates development of novel, femto-cell technology, and seamless coexistence with first round legacy deployment. Such scenario also requires novel channel models and simulation methodologies to attain the desired trade-off between coverage, throughput and densification limits. EWOC will rely on fiber-optic deployment towards ToF connectivity, as an “added on feature” for the C-RAN architecture supporting resource management of versatile services with varying demands. Scenario compliant optical fronthaul virtualisation techniques, designed to provide cost effective beyond state-of-the-art resource optimisation, will be pursued through novel optical transceiver schemes and software defined network-based digital signal processing techniques. Research and training disciplines will serve as building blocks towards the scientific and socio-economic goals of increased capacity, coverage, flexibility, spectral efficiency, cost effectiveness, vendor agnosticism, and upgradability. EWOC provides a framework for promotion of such interdisciplinary innovation, with strong interoperability of models and methodologies from different disciplines. As such, EWOC training network is designed to foster opportunities for scientific and professional growth of ESRs from both topical and inter-disciplinary standpoints.

Keywords: c ran virtualization femto cells mm wave wdm pon sdn
Making patient-derived tumor organoids a reliable cancer therapy testing platform (TUMORGPLAT)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Staff Exchanges
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Spain,Italy,United Kingdom
Call: MSCA Staff Exchanges 2024 (HORIZON-MSCA-2024-SE-01, 2024)
Start date: 2026-01-01
End date: 2029-12-31
Duration (months): 48.0
Total project cost (EUR): 251931.43
EU funding (EUR): 245490.0
Participants: 6
Project status: SIGNED

We aim to establish a European network of experts in non-animal preclinical models to develop the next generation of patient-derived tumor organoids (PDTOs) for both solid and hematological cancers. To this end, we have selected non-small cell lung cancer as a model, given its high incidence, and chronic lymphocytic leukemia and follicular lymphoma as representative B cell malignancies. These PDTOs will incorporate a novel, tissue-specific artificial extracellular matrix, created using tailored 3D biohybrid hydrogels designed to mimic the human tumor microenvironment (TME). By integrating patient-derived tumor, immune, and stromal cells, the PDTOs will closely replicate the complexity of the original tumors, which will be evaluated using a multi-technique approach, including comprehensive omics characterization. Our ultimate goal is to establish a robust platform for testing innovative therapies—particularly radiotherapy and immunotherapy—within the framework of personalized medicine. Specifically, we will focus on adoptive cell therapies using CAR T and NK cells, neutron capture (radio)therapy, and their combination.

Keywords: biomaterials,tissue engineering,3d biohybrid hydrogels,organoids,non animal preclinical models,nsclc,cll,fl,immunotherapy,neutron capture therapy,cancer,personalized medicine